Skip to main content

Table 3 Medication Associated To MRVs

From: Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis

ATC classes

 

Total MRVs (n = 497)

n(%)

True MRVs

(n = 232)

n(%)

Potential MRVs

(n = 265)

n(%)

Medication-related ADRs

(n = 87)

n(%)

Antiinfectives for systemic use

144

(28.9)

129

(55.6)

15

(5.6)

52

(59.7)

 Vaccines

65

(45.1)

65

(50.3)

-

-

-

-

 Beta-Lactam Antibacterials

59

(40.9)

47

(36.4)

12

(80.0)

43

(82.6)

 Macrolides, Lincosamides and Streptogramins

15

(10.4)

12

(9.3)

3

(20)

5

(9.6)

Nervous System

111

(22.3)

40a

(17.2)

71

(26.7)

7

(8.0)

 Paracetamol

34

(30.6)

13

(32.5)

21

(29.5)

1

(14.2)

 Psycholepticts

29

(26.1)

9

(22.5)

20

(28.1)

-

-

 Antidepressants

17

(15.3)

7

(17.5)

10

(14.0)

-

-

 Antiepileptics

14

(12.6)

5

(12.5)

9

(12.6)

3

(42.8)

 Opioids

5

(4.5)

1

(2.5)

4

(5.6)

1

(14.2)

Respiratory System

54

(10.8)

14b

(6)

40

(15

6

(6.8)

 Adrenergics, Inhalants

18

(33.3)

8

(57.1)

10

(25)

3

(50)

 Antihistamines for Systemic Use

17

(31.4)

3

(21.4)

14

(35)

-

-

 Cough and Cold Preparations

10

(18.5)

2

(14.2)

8

(20)

2

(33.3

Alimentary Tract and Metabolism

52

(10.4)

15c

(6.4)

37

(13.9

7

(8.0)

 Drugs for Functional Gastrointestinal Disorders (domperidone, metoclopramide, cimetropium bromide)

15

(28.8)

4

(26.6)

11

(29.7)

2

(28.5)

 Stomatological Preparations

10

(19.2)

1

(6.6)

9

(24.3)

-

-

 Blood Glucose Lowering Drugs, Excl. Insulins

7

(13.4)

4

(26.6)

3

(8.1)

-

-

 Vitamins

6

(11.5)

2

(13.3)

4

(10.8)

1

(14.2)

 Drugs for Acid Related Disorders

4

(7.6)

-

-

411

(36.3)

-

-

 Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents

4

(7.6)

1

(6.6)

3

(8.1)

1

(14.2)

 Drugs for Constipation

3

(5.7)

1

(6.6)

2

(5.4)

1

(14.2)

 Antiemetics and Antinauseants

2

(3.8)

2

(13.3)

-

-

2

(28.5)

Musculo-Skeletal System

36

(7.2)

14

(6)

22

(8.3)

11

(12.6)

 NSAIDs (ketoprofen, ibuprofen)

31

(86.1)

14

(100)

17

(77.2)

11

(100)

  1. a18(45) cases were drug use without indication-related event, 10(25) cases were supratherapeutic dosage-related event, 5(12.5) cases were improper drug selection-related event;
  2. b5(35.7) cases were drug use without indication-related event, 2(14.2) cases were supratherapeutic dosage-related event, 1(7.1) cases were improper drug selection-related event;
  3. c5(33.3) cases were drug use without indication-related event, 3(20) cases were supratherapeutic dosage-related event;